SCHEMBL3846904

SCHEMBL3846904

Cc1ccn(-c2ncnc3ccc(-c4c[nH]nc4-c4c(F)cccc4F)cc23)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 13/20 0.38
CYP3A4 P08684 13/20 0.38
CYP2C19 P33261 12/20 0.38
ALDH1A1 P00352 11/20 0.38
CLK4 Q9HAZ1 11/20 0.38
LMNA P02545 9/20 0.38
CYP2D6 P10635 6/20 0.38
HSD17B10 Q99714 4/20 0.38
TP53 P04637 2/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
MAP4K4 O95819 1/20 0.36
HIF1A Q16665 8/20 0.36
TSHR P16473 7/20 0.36
USP2 O75604 7/20 0.36
MAPK1 P28482 7/20 0.36
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850726 0.84 CYP1A2 (0.37) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3850082 0.84 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3846896 0.79 CYP3A4 (0.36) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3850421 0.75 MAP4K4 (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3854840 0.74 MAP4K1 (0.46) MAP4K4
SCHEMBL3846793 0.71 MAP4K4 (0.36) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3844989 0.69 MAP4K4 (0.34) CYP1A2CYP3A4CYP2C19LMNACYP2D6
SCHEMBL3847232 0.67 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3847007 0.67 HTT (0.53) ALDH1A1LMNAHIF1AMAPK1MEN1
SCHEMBL3848419 0.67 CYP3A4 (0.63) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed